Global Memantine Market, By Drug Class (N-Methyl-D-aspartate (NMDA) Receptor Antagonist, Others), Application (Alzheimer's Disease, Others), Demographic (Adult, Pediatric), Dosage Form (Tablets,, Oral Solution, Extended Release Capsule), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Memantine Market
Memantine market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.20% in the above mentioned forecast period.
Memantine is N-Methyl-D-aspartate (NMDA) receptor antagonist. It is a prescription medication used to treat moderate to severe dementia (confusion) caused by Alzheimer's disease. It is not a cure for Alzheimer's disease, although it may help with memory, alertness, and daily functions. This medicine acts by inhibiting the function of a natural molecule in the brain called glutamate, which is connected to Alzheimer's disease symptoms. Namenda XR and Namenda are the different brand names for memantine.
The rise in the prevalence of Alzheimer's disease across the world will act a major driver for the expansion of memantine market. Furthermore, upsurge in the number of pipe line studies, increasing geriatric population and rising healthcare expenditure are the factors that will expand the memantine market. Other factors including changing lifestyle and rising awareness will positively impact the market growth rate. Additionally, advancement in the medical technology, growing government funding and rising level of disposable incomes are the factors that will escalate the growth rate of memantine market.
Moreover, the rise in the research and development activities and emerging new markets will provide beneficial opportunities for the memantine market in the forecast period of 2022-2029.
However, high cost of the drug and side effects associated with memantine such headache, nausea, vomiting, dizziness, nervousness, seizures and others. All these factors hamper the market growth. Lack of awareness and growing number of expired patents of drugs will further challenge the memantine market in the forecast period mentioned above.
This memantine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the memantine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Memantine Market Scope and Market Size
The memantine market is segmented on the basis of drug class, application, demographic, dosage form, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the memantine market is segmented into N-Methyl-D-aspartate (NMDA) receptor antagonist and others.
- On the basis of application, the memantine market is segmented into Alzheimer's disease and others.
- On the basis of demographic, the memantine market is segmented into adult, and pediatric.
- On the basis of dosage form, the memantine market is segmented into tablets, oral solution, and extended release capsule. Tablets are further sub-segmented into 5mg, and 10mg. Extended release capsule are further sub-segmented into 7mg, 14mg, 21mg and 28mg. Oral solution is further sub-segmented into 2mg/ml.
- On the basis of end-users, the memantine market is segmented into clinic, hospital and others.
The memantine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Memantine Market Country Level Analysis
Memantine market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, end-users and distribution channel as referenced above.
The countries covered in the memantine market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the memantine market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Memantine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Memantine Market Share Analysis
Memantine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to memantine market research.
Some of the major players operating in the memantine market are DAIICHI SANKYO COMPANY, LIMITED., Novartis AG, Allergan, Sanofi, Lupin, Eisai Co., Ltd., Johnson & Johnson Private Limited, Dr. Reddy’s Laboratories Ltd., H. Lundbeck A/S, ONO PHARMACEUTICAL CO., LTD., Merz Pharma, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Apotex Inc., and Sun Pharmaceutical Industries Ltd., among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
